LLYon logo

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insul...

NYSEHealthcareDrug Manufacturers - GeneralUSA

Company Profile

Stock Code
LLY
ISIN Code
US5324571083
Currency
US Dollar (USD)
IPO Date
1978-01-13

Contact Information

Company Address
Lilly Corporate Center, Indianapolis, IN, United States, 46285
Contact Phone
317 276 2000
Company Website
https://www.lilly.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
0.61%
Return on Assets (TTM)
20.74%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99